// App-Quantinova.ai

323 : Early identification of candidates for second‐ line therapies in PBC using a UDCA‐response model

Researchers

Presenter

  • Marco Carbone

Principal Investigators

  • Alessandra Nardi

  • Guido Carpino

  • Holly Ainsworth

  • Vincenzo Cardinale

  • Michael A. Heneghan

  • Gideon M. Hirschfield

  • Douglas Thorburn

  • Andrew Bathgate

  • James M. Neuberger

  • Rebecca Jones

  • Heather J. Cordell

  • Graeme J. Alexander

  • Deborah Stocken

  • Richard N. Sandford

  • Pietro Invernizzi

  • David Jones

  • George F. Mells

Medical Centers

  • Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom

  • Division of Gastroenterology, University of Milan Bicocca, Milan, Italy

  • Department of Biology, University of Rome Tor Vergata, Rome, Italy

  • Insti- tute of Health and Society, Newcastle University, Newcastle, United Kingdom

  • Division of Gastroenterology, University of Rome la Sapienza, Rome, Italy

  • Institute of Liver Studies, Kings CollegeHospital NHS Trust, London , United Kingdom

  • Centre for Liver Research, Institute of Biomedical Research,, University of Birmingham, Birmingham, United Kingdom

  • Sheila Sherlock Liver Centre, Royal Free Hospital London,

  • Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom

  • St. James's University Hospital, Leeds, United Kingdom

  • Institute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, UK

  • Oncology Centre, Addenbrookes Hospital, Cambridge, United Kingdom

  • Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Alkaline phosphatase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved